Loading…
Nu Skin Enterprises, Inc. is projected to rise to $6.59 by 2027, a +27% move from its current price of $5.19. NUS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $5.09 | $5.19 | $5.30 | +0.05% |
| Aug 4 | $5.05 | $5.20 | $5.34 | +0.10% |
| Aug 5 | $5.02 | $5.20 | $5.38 | +0.15% |
| Aug 6 | $5.00 | $5.20 | $5.41 | +0.20% |
| Aug 7 | $4.98 | $5.20 | $5.44 | +0.26% |
| Aug 8 | $4.96 | $5.21 | $5.47 | +0.31% |
| Aug 9 | $4.94 | $5.21 | $5.49 | +0.36% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.94 | $5.21 | $5.49 | +0.36% |
| Week 2 | $4.85 | $5.23 | $5.63 | +0.72% |
| Week 3 | $4.79 | $5.25 | $5.75 | +1.08% |
| Week 4 | $4.74 | $5.26 | $5.85 | +1.44% |
| Week 5 | $4.70 | $5.28 | $5.94 | +1.80% |
| Week 6 | $4.66 | $5.30 | $6.03 | +2.16% |
| Week 7 | $4.63 | $5.32 | $6.12 | +2.53% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty and Beauty Focus wellness brands.
The company also provides wellness products, such as ageLOC TRME, LifePak, and Beauty Focus. In addition, it is the research and product development of skin care products, nutritional supplements, and devices. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center and independent marketers.
It serves Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, comprising Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, consists of Macau; and Europe & Africa, which includes markets in Europe as well as South Africa. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
It is categorized in the Consumer Defensive sector.
Nu Skin Enterprises, Inc. (NUS) currently trades at $5.39 per share and has a market capitalization of $261.69M, ranking 3547 by market cap. The current price sits within a near-term range that the forecast envisions as a springboard to stronger gains over the coming years.
The price outlook, based on the provided year-by-year forecast, shows a path of gradual to strong upside. The model places the 2026 average at $5.39 and projects rising averages thereafter, with notable bullish momentum from 2027 onward and an eventual multi-decade upside to a 2050 average of $25.03. The longer-horizon figures imply substantial returns relative to the current level, though these are estimates, not guarantees.
In the nearer term, the forecast hints at continued positive sentiment for the stock, while the longer horizon highlights meaningful upside potential through 2040 ($15.13 average) and 2050 ($25.03 average). These projections are conditional on market dynamics and should be interpreted as estimates rather than certainties.
A major floor 9.0% below — a decisive break under it would weaken the trend.
The nearest floor, 4.8% below — buyers have tended to step in here.
The nearest ceiling, 3.9% above — a clean break opens room to run.
A major ceiling 52.2% above — clearing it would confirm fresh momentum.
Key NUS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NUS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.22 | Sell | $5.21 | Sell |
| MA 10 | $5.21 | Sell | $5.21 | Sell |
| MA 20 | $5.19 | Buy | $5.21 | Sell |
| MA 50 | $5.32 | Sell | $5.52 | Sell |
| MA 100 | $6.26 | Sell | $6.31 | Sell |
| MA 200 | $8.12 | Sell | $7.37 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 47.45 | Neutral |
| Stoch RSI (14) | 64.57 | Neutral |
| CCI (20) | 2.01 | Neutral |
| Williams %R (14) | -47.62 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 0.39 | Buy |
| Bollinger %B (20,2) | 0.51 | Neutral |
| Stochastic %K (14) | 52.38 | Neutral |
| TRIX (15) | -0.15 | Sell |
| Awesome (5,34) | 0.05 | Buy |
| Ultimate (7,14,28) | 48.41 | Neutral |
| Momentum (10) | -0.05 | Sell |
| Aroon Osc (25) | 56.00 | Buy |
| Hull MA (9) | 5.26 | Sell |
| ADX (14) | 13.61 | Neutral |
| ATR (14) | 0.09 | Info |
The 30-day technical picture is NEUTRAL, with RSI14 at 50. The price remains near the mid-point of its near-term trajectory, trading around the 50-day view.
Key near-term indicators show a SMA50 of $5.62 and a SMA200 of $8.46, suggesting resistance above the current level given the longer-term gauge. Support is identified at $4.94 and resistance at $5.47, framing a tight 30-day range between $4.57 and $6.36. Traders may watch for a break beyond the $5.47 resistance or a test of support near $4.94 for clues on the next move.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.94 | $5.19 | $7.21 | 0% | Neutral | |
| $5.38 | $6.59 | $8.43 | +27% | Bullish | |
| $5.58 | $6.96 | $9.17 | +34% | Bullish | |
| $5.55 | $7.05 | $9.50 | +36% | Bullish | |
| $5.71 | $7.34 | $10.08 | +42% | Bullish | |
| $5.76 | $7.52 | $10.49 | +45% | Bullish | |
| $6.18 | $8.15 | $11.55 | +57% | Bullish | |
| $7.21 | $9.62 | $13.81 | +85% | Bullish | |
| $7.52 | $10.14 | $14.75 | +95% | Bullish | |
| $7.74 | $10.54 | $15.51 | +103% | Bullish | |
| $9.94 | $14.16 | $21.88 | +173% | Bullish | |
| $15.57 | $23.93 | $39.74 | +361% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $4.94 | $5.19 | $6.36 | +0.00% |
| September 2026 | $4.64 | $5.44 | $6.54 | +4.85% |
| October 2026 | $4.61 | $5.44 | $6.58 | -0.09% |
| November 2026 | $4.74 | $5.61 | $6.84 | +3.25% |
| December 2026 | $4.95 | $5.89 | $7.21 | +4.89% |
Click any year to see its month-by-month NUS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The NUS price prediction for 2026 points to an average of $5.19 (low $4.94, high $7.21) — a potential gain of 0% on today's $5.19. A consolidation phase looks the most probable path here.
In 2027, NUS is projected to trade between $5.38 and $8.43, averaging $6.59 — a potential gain of +27% from today's $5.19. That is up +27% on the projected 2026 average. Momentum favours further upside here.
Nu Skin Enterprises, Inc.'s 2028 outlook centres on $6.96, within a $5.58 to $9.17 range. That is up +6% on the projected 2027 average. That marks a +34% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, NUS could reach as high as $9.50, with a base case around $7.05 and support toward $5.55 — roughly +36% from $5.19. Momentum favours further upside here.
Expect NUS to range from $5.71 to $10.08 through 2030. The $7.34 average target implies a +42% move from current prices. That is up +4% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The NUS price prediction for 2031 points to an average of $7.52 (low $5.76, high $10.49) — a potential gain of +45% on today's $5.19. Momentum favours further upside here.
In 2032, NUS is projected to trade between $6.18 and $11.55, averaging $8.15 — a potential gain of +57% from today's $5.19. That is up +8% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Nu Skin Enterprises, Inc.'s 2033 outlook centres on $9.62, within a $7.21 to $13.81 range. That is up +18% on the projected 2032 average. That marks a +85% change versus current levels. Momentum favours further upside here.
By 2034, NUS could reach as high as $14.75, with a base case around $10.14 and support toward $7.52 — roughly +95% from $5.19. Buyers look set to stay in control over this stretch.
Expect NUS to range from $7.74 to $15.51 through 2035. The $10.54 average target implies a +103% move from current prices. That is up +4% on the projected 2034 average. Momentum favours further upside here.
The NUS price prediction for 2040 points to an average of $14.16 (low $9.94, high $21.88) — a potential gain of +173% on today's $5.19. Buyers look set to stay in control over this stretch.
In 2050, NUS is projected to trade between $15.57 and $39.74, averaging $23.93 — a potential gain of +361% from today's $5.19. That is up +69% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in NUS today (≈ 192.678227 NUS) could be worth
$4,610.17
+$3,610.17 (+361%) by 2050 · US Dollar
Based on the average projected NUS price of $23.93 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NUSwould be worth at today's price.
$1,000 invested in NUS on Jul 31, 2025 (≈ 119.331741 NUS) would be worth
$619.33
-$380.67 (-38.1%) today · 0.62× · US Dollar
Based on a NUS entry price of $8.38 vs. today's $5.19.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.08 | $1,021.65 | +2.2% |
| 1 month ago | $5.25 | $988.57 | -1.1% |
| 3 months ago | $7.19 | $721.84 | -27.8% |
| 6 months ago | $10.53 | $492.88 | -50.7% |
| 1 year ago | $8.38 | $619.33 | -38.1% |
| All time (5.0y) ago | $54.27 | $95.63 | -90.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NUS forecast.
Our base-case forecast reaches $10.00 around 2034.
Implied market cap at $10.00: $485.51M
Looking further out, the multi-year forecast displays a bullish trajectory with rising averages and expanding upside. The 2027 forecast shows a min of $5.52, an avg of $6.88 and a max of $9.05, with ROI of 27.7 and sentiment BULLISH. The 2028 forecast carries an avg of $7.47 (min $5.85, max $10.16) and ROI 38.6, followed by 2029 at an avg of $7.44 (min $5.70, max $10.39) and ROI 38, still BULLISH.
In 2030 the avg is projected at $7.60 (min $5.72, max $10.87) with ROI 41.1 and a BULLISH sentiment, then 2031 at $7.96 and 2032 at $8.51. The 2033 forecast jumps to an avg of $10.17 (min $7.30, max $15.35) with ROI 88.8, followed by 2034 at $10.96 (min $7.75, max $16.78) ROI 103.3 and 2035 at $11.00 (min $7.68, max $17.08) ROI 104.1, all Bullish.
The horizon widens further to 2040 with an avg of $15.13 (min $9.95, max $24.91) and ROI 180.8, then to 2050 with an avg of $25.03 (min $14.86, max $44.85) and ROI 364.4. These are estimates, not guarantees, and reflect the stated price forecast at each horizon.
Tap a question to reveal the answer.
The 2030 forecast shows min $5.72, avg $7.60, max $10.87, ROI 41.1, sentiment BULLISH.
The forecast indicates a bullish trajectory across multiple years, with 2040 avg $15.13 (ROI 180.8) and 2050 avg $25.03 (ROI 364.4). These are estimates, not guarantees, and reflect potential upside from the current level.
Yes. The forecast lists a max of $10.87 in 2030 and a max of $15.35 in 2033 (also $16.78 in 2034), with 2030 the first year to exceed $10 on the max case.
Avg $6.88, min $5.52, max $9.05, ROI 27.7, sentiment BULLISH.
Nu Skin Enterprises, Inc. Community Discussion
0Share your Nu Skin Enterprises, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.